BLDEW · Insider Trading

Blade Air Mobility, Inc. Warrants

Every open-market purchase and sale reported by BLDEW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
7
code S
Reporting Insiders
12
current holders
BLDEW — Recent Form 4 Transactions (latest 2025-08-18)
FiledInsiderRole TypeSharesValue
2025-08-18 Scott M Wunsch CEO, Trinity Air Medical A +22,365 —
2025-08-07 Robert S Wiesenthal Chief Executive Officer M +282,470 +$50.84K
2025-08-07 Melissa M. Tomkiel President and General Counsel M +44,445 +$8.00K
2025-08-05 Reginald Love Director A +35,534 —
2025-08-05 Andrew Lauck Director A +35,534 —
2025-08-05 Eric Affeldt Director A +35,534 —
2025-08-05 William A. Heyburn Chief Financial Officer MIXED +16,191 −$535.77K
2025-08-05 John Borthwick Director A +35,534 —
2025-08-05 Edward M Philip Director A +35,534 —
2025-08-05 Kenneth B Lerer Director A +35,534 —
2025-08-05 Susan M Lyne Director A +35,534 —
2025-08-05 Amir Cohen Chief Accounting Officer MIXED +16,717 −$61.55K
2025-08-05 Melissa M. Tomkiel President and General Counsel MIXED +31,648 −$560.61K
2025-08-05 Robert S Wiesenthal Chief Executive Officer MIXED +110,166 −$543.69K
2025-06-11 Robert S Wiesenthal Chief Executive Officer F −91,031 −$345.92K
2025-06-11 William A. Heyburn Chief Financial Officer MIXED −135,348 −$540.91K
2025-06-11 Amir Cohen Chief Accounting Officer F −3,708 −$14.09K
2025-06-11 Melissa M. Tomkiel President and General Counsel MIXED −134,018 −$536.80K
2025-06-11 Scott M Wunsch CEO, Trinity Air Medical F −2,190 −$8.32K
2025-05-07 Andrew Lauck Director A +83,264 —
2025-05-07 Scott M Wunsch CEO, Trinity Air Medical A +8,253 —
2025-03-28 Robert S Wiesenthal Chief Executive Officer MIXED +519,796 −$1.92M
2025-03-28 Melissa M. Tomkiel President and General Counsel M +55,556 +$10.00K
2025-03-17 Amir Cohen Chief Accounting Officer MIXED +19,359 −$100.06K
2025-03-17 Robert S Wiesenthal Chief Executive Officer MIXED +84,594 −$966.24K
2025-03-17 Scott M Wunsch CEO, Trinity Air Medical MIXED −13,831 −$97.43K
2025-03-17 William A. Heyburn Chief Financial Officer MIXED +62,782 −$499.43K
2025-03-17 Melissa M. Tomkiel President and General Counsel MIXED +90,526 −$519.85K
2025-03-17 Scott M Wunsch CEO, Trinity Air Medical MIXED +4,462 −$8.03K
2025-01-10 Melissa M. Tomkiel President and General Counsel M +100,000 +$18.00K
2025-01-08 William A. Heyburn Chief Financial Officer MIXED +70,430 −$493.52K
2024-12-23 William A. Heyburn Chief Financial Officer M +25,312 +$4.56K
2024-12-23 Robert S Wiesenthal Chief Executive Officer MIXED +527,679 −$2.55M
2024-12-17 John Borthwick Director MIXED +26,097 −$280.89K
2024-12-17 Reginald Love Director Sell −5,091 −$20.62K
2024-12-11 Amir Cohen Chief Accounting Officer F −4,893 −$23.09K
2024-12-11 Scott M Wunsch CEO, Trinity Air Medical F −20,641 −$97.43K
2024-12-11 Melissa M. Tomkiel President and General Counsel MIXED −56,504 −$273.26K
2024-12-11 William A. Heyburn Chief Financial Officer MIXED −74,633 −$363.86K
2024-12-11 Robert S Wiesenthal Chief Executive Officer F −91,031 −$429.67K
2024-12-04 Amir Cohen Chief Accounting Officer Sell −10,150 −$45.23K
2024-12-03 William A. Heyburn Chief Financial Officer Sell −23,815 −$119.63K
2024-12-03 Eric Affeldt Director G −50,000 —
2024-12-03 Eric Affeldt Director — — —
2024-11-29 Melissa M. Tomkiel President and General Counsel Sell −111,377 −$501.62K
2024-11-19 William A. Heyburn Chief Financial Officer M +24,688 +$4.44K
2024-11-15 Robert S Wiesenthal Chief Executive Officer Sell −2,100,000 −$6.76M
2024-11-13 Melissa M. Tomkiel President and General Counsel Sell −44,621 −$151.54K
2024-09-13 Robert S Wiesenthal Chief Executive Officer F −91,030 −$259.44K
2024-09-13 Amir Cohen Chief Accounting Officer Sell −4,891 −$13.94K
BLDEW — Current Insider Holders
InsiderRole Shares HeldValue
Robert S Wiesenthal Chief Executive Officer 6,155,535 $1.10M
William A. Heyburn Chief Financial Officer 1,463,940 $262.63K
Melissa M. Tomkiel President and General Counsel 1,169,334 $209.78K
Scott M Wunsch CEO, Trinity Air Medical 687,008 $123.25K
Eric Affeldt Director 581,214 $104.27K
Edward M Philip Director 234,165 $42.01K
Kenneth B Lerer Director 223,696 $40.13K
John Borthwick Director 203,977 $36.59K
Susan M Lyne Director 187,185 $33.58K
Reginald Love Director 135,897 $24.38K
Andrew Lauck Director 118,798 $21.31K
Amir Cohen Chief Accounting Officer 91,916 $16.49K
BLDEW Insider Trading FAQ
Who are the insiders at BLDEW?
12 officers, directors and 10%+ beneficial owners currently report holdings in BLDEW via SEC Form 4.
Are BLDEW insiders buying or selling?
Across the 50 most recent Form 4 filings for BLDEW, 0 were open-market purchases (code P) and 7 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is BLDEW insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent BLDEW filing is dated 2025-08-18.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the BLDEW quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.